Literature DB >> 24937955

Subsequent pregnancy outcomes after complete and partial molar pregnancy, recurrent molar pregnancy, and gestational trophoblastic neoplasia: an update from the New England Trophoblastic Disease Center.

Roberto Vargas, Lisa M Barroilhet, Katharine Esselen, Elisabeth Diver, Marilyn Bernstein, Donald P Goldstein, Ross S Berkowitz.   

Abstract

OBJECTIVE: To review and update the subsequent reproductive outcomes in patients with complete, partial, and recurrent hydatidiform moles, as well as gestational trophoblastic neoplasia (GTN) at the New England Trophoblastic Disease Center. STUDY
DESIGN: Patients with complete and partial hydatidiform mole, recurrent hydatidiform mole, and GTN were identified from the Donald P. Goldstein, M.D., Trophoblastic Tumor Registry. Questionnaires regarding subsequent pregnancies were mailed to patients with current mailing addresses available. Additional patient data was obtained from electronic medical records.
RESULTS: A total of 2,432 subsequent pregnancies have been reported since 1965. Of those, 1,388 pregnancies were after complete mole, 357 after partial mole, and 667 after GTN. The subsequent reproductive outcomes in patients with complete and partial molar pregnancies and persistent GTN remain similar to those in the general population. However, approximately 1.7% of patients with a prior molar pregnancy had a molar pregnancy in a later gestation. Furthermore, after successful chemotherapy for GTN the incidence of stillbirth was slightly increased to 1.3% in later pregnancies.
CONCLUSION: Patients with molar pregnancies and GTN should expect similar reproductive outcomes as compared to the general population. However, patients receiving chemotherapy for GTN have a slightly increased risk stillbirth in subsequent pregnancies.

Entities:  

Mesh:

Year:  2014        PMID: 24937955

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  11 in total

1.  Live euploid birth and complete hydatid mole, followed by partial hydatid mole after ICSI.

Authors:  Ming-Tzeung Chung; Chii-Ruey Tzeng; Ching-Hui Chen; Cindy Chan; Yi-En Chang; Yi-Hua Wu; Chi-Huang Chen
Journal:  J Assist Reprod Genet       Date:  2018-06-02       Impact factor: 3.412

2.  The genomic architecture of NLRP7 is Alu rich and predisposes to disease-associated large deletions.

Authors:  Ramesh Reddy; Ngoc M P Nguyen; Guillaume Sarrabay; Maryam Rezaei; Mayra C G Rivas; Aysenur Kavasoglu; Hakan Berkil; Alaa Elshafey; Ebtesam Abdalla; Kristin P Nunez; Hélène Dreyfus; Merviel Philippe; Zahra Hadipour; Asude Durmaz; Erin E Eaton; Brittany Schubert; Volkan Ulker; Fatemeh Hadipour; Fatemeh Ahmadpour; Isabelle Touitou; Majid Fardaei; Rima Slim
Journal:  Eur J Hum Genet       Date:  2016-03-09       Impact factor: 4.246

3.  Gestational and Non-gestational Trophoblastic Disease. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No. 032/049, December 2015).

Authors:  C Tempfer; L-C Horn; S Ackermann; M W Beckmann; R Dittrich; J Einenkel; A Günthert; H Haase; J Kratzsch; M C Kreissl; S Polterauer; A D Ebert; K T M Schneider; H G Strauss; F Thiel
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-02       Impact factor: 2.915

4.  High Incidence of Gestational Trophoblastic Disease in a Third-Level University-Hospital, Italy: A Retrospective Cohort Study.

Authors:  Giampiero Capobianco; Elettra Tinacci; Laura Saderi; Francesco Dessole; Marco Petrillo; Massimo Madonia; Giuseppe Virdis; Alessandro Olivari; Davide Adriano Santeufemia; Antonio Cossu; Salvatore Dessole; Giovanni Sotgiu; Pier Luigi Cherchi
Journal:  Front Oncol       Date:  2021-05-05       Impact factor: 6.244

Review 5.  Clinical and radiological correlations in patients with gestational trophoblastic disease.

Authors:  Lana de Lourdes Aguiar Lima; Raphael Câmara Medeiros Parente; Izildinha Maestá; Joffre Amim Junior; Jorge Fonte de Rezende Filho; Carlos Antonio Barbosa Montenegro; Antônio Braga
Journal:  Radiol Bras       Date:  2016 Jul-Aug

6.  Incidence of gestational trophoblastic disease in South Korea: a longitudinal, population-based study.

Authors:  Jin-Sung Yuk; Jong Chul Baek; Ji Eun Park; Hyen Chul Jo; Ji Kwon Park; In Ae Cho
Journal:  PeerJ       Date:  2019-02-20       Impact factor: 2.984

Review 7.  Understanding and management of gestational trophoblastic disease.

Authors:  Fen Ning; Houmei Hou; Abraham N Morse; Gendie E Lash
Journal:  F1000Res       Date:  2019-04-10

8.  Prophylactic Chemotherapy with Methotrexate Leucovorin in High-Risk Hydatidiform Mole.

Authors:  Soheila Aminimoghaddam; Fatemeh Mahmoudzadeh; Marzieh Mohammadi
Journal:  Asian Pac J Cancer Prev       Date:  2020-06-01

9.  Hydatidiform Mole in a Patient With a Concern for Neoplasia: A Case Report.

Authors:  Indraneel K Prabhu; Amy Rosenbaum
Journal:  Cureus       Date:  2020-09-08

Review 10.  Early pregnancy following multidrug regimen chemotherapy in a gestational trophoblastic neoplasia patient: A case report.

Authors:  Gang Niu; Lin-Jing Yuan; Feng-Qiu Gong; Juan Yang; Cai-Xia Zhu; Hong-Wei Shen
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.